Entries of Weigt, Carmen on the publication server
 | Up a level |
Jump to: 2023
Number of items: 2.
2023
Hart, Christina, Klamroth, Robert, Sachs, Ulrich J., Greil, Richard 
, Knoebl, Paul N., Oldenburg, Johannes, Miesbach, Wolfgang, Pfrepper, Christian , Trautmann-Grill, Karolin, Pekrul, Isabell, Holstein, Katharina, Eichler, Hermann, Weigt, Carmen, Schipp, Dorothea, Werwitzke, Sonja and Tiede, Andreas
(2023)
Emicizumab Versus Immunosuppression for Acquired Hemophilia Α (AHA).
Blood 142 (Supple), p. 2612.
Tiede, Andreas, Hart, Christina, Knöbl, Paul , Greil, Richard, Oldenburg, Johannes, Sachs, Ulrich J, Miesbach, Wolfgang, Pfrepper, Christian, Trautmann-Grill, Karolin, Holstein, Katharina, Pilch, Jan, Möhnle, Patrick, Schindler, Christoph, Weigt, Carmen, Schipp, Dorothea, May, Marcus , Dobbelstein, Christiane, Pelzer, Fabius J, Werwitzke, Sonja and Klamroth, Robert
(2023)
Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study.
The Lancet Haematology 10 (11), e913-e921.
Fulltext not available.
, Greil, Richard, Oldenburg, Johannes, Sachs, Ulrich J, Miesbach, Wolfgang, Pfrepper, Christian, Trautmann-Grill, Karolin, Holstein, Katharina, Pilch, Jan, Möhnle, Patrick, Schindler, Christoph, Weigt, Carmen, Schipp, Dorothea, May, Marcus , Dobbelstein, Christiane, Pelzer, Fabius J, Werwitzke, Sonja and Klamroth, Robert
(2023)
Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study.
The Lancet Haematology 10 (11), e913-e921.
Fulltext not available.